More about
Administration, Intranasal
News
October 11, 2023
2 min read
Save
Intranasal COVID-19 vaccine candidate generates robust immune response
BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response in a phase 1 trial, researchers reported.